Viral infections continue to pose major threats to global health, underscoring the urgent need for more effective antiviral therapeutics. Antiviral drug discovery traditionally follows two paradigms: phenotype-based drug discovery (PBDD) and target-based drug discovery (TBDD). Here, we present DeepAVC, a large language model (LLM)-powered unified framework that integrates DeepPAVC for PBDD and DeepTAVC for TBDD, enabling complementary and end-to-end antiviral compound prediction.
Users only need to input compounds in SMILES format. DeepPAVC predicts antiviral activity at the phenotype level, while DeepTAVC estimates interactions with known antiviral targets. For large-scale proteome-wide profiling, the CADTI module supports compound–all-target interaction prediction. These three modes can be used independently or in combination to meet diverse research needs.
Enter your compounds in SMILES format and select the prediction task below.
Download the pre-trained DeepPAVC model for phenotype-based antiviral compounds prediction.
Download the pre-trained DeepTAVC model for target-based antiviral compounds prediction.
Download the pre-trained CADTI model for general compound-protein interaction prediction.
Download the pre-trained KPGT model for compound feature extraction.
Download the pre-trained ESM-2 (650M) model for protein feature extraction.
Download the pre-trained ESM-2 (650M) model for protein feature extraction.
Download the pre-trained ESM-2 (15B) model for protein feature extraction.
Download the pre-trained ESM-2 (15B) model for protein feature extraction.
Download the source code of DeepAVC.
The source code for the DeepAVC algorithm is also available on GitHub.
Viral infections pose ongoing threats to human health, emphasizing the continued need for effective antiviral therapeutics. Antiviral drug discovery traditionally follows two paradigms: phenotype-based drug discovery (PBDD) and target-based drug discovery (TBDD).
DeepAVC is a unified large language model-powered framework integrating DeepPAVC (phenotype-based prediction) and DeepTAVC (target-based prediction). The framework enables end-to-end antiviral compound discovery from phenotype screening to target interaction prediction.
Enter one compound per line in the SMILES input box. You may click the Example button to load sample compounds.
After entering SMILES, select one or more prediction modes based on your research needs.
Click the Run Prediction button to submit your job. The server will process the input and display prediction results automatically.
⚠ Note: All-target prediction is computationally intensive and supports limited compound input.